SAB Biotherapeutics, Inc.

Ownership Transactions Reported by 28 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+17.7 K	100%	$0.89	+$15.9 K
Sells	0
Net	+3	+17.7 K	100%		+$15.9 K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Sessa Capital (Master), L.P.	Director	$32.4 M			Nov 24, 2023
Andrew Moin	Director	$32.4 M			Nov 24, 2023
Edward D. Hamilton	10%+ Owner	$9.35 M			Oct 22, 2021
Eddie J. Sullivan	PRESIDENT, Director	$4.6 M	+$1.53 K	+0.03%	Feb 21, 2024
E. Hamilton	Director, 10%+ Owner	$4.42 M			Dec 31, 2022
Ilan Katz	Director, 10%+ Owner	$2.68 M			Oct 13, 2021
Helen K. Ellias	Director	$2.51 M			Nov 24, 2023
Samuel J. Reich	CEO & EXECUTIVE CHAIRMAN, Director	$675 K	+$9.84 K	+1.48%	Feb 21, 2024
Alexandra Kropotova	Chief Medical Officer	$242 K			Feb 21, 2024
David Charles Link	Director	$50.4 K			Dec 7, 2022
Michael King	Chief Financial Officer	$4.4 K	+$4.5 K		Feb 21, 2024
Christoph Bausch	Chief Operating Officer				Feb 21, 2024
Mervyn Turner	Director				Oct 22, 2021
Jerry Lynn Pommer	Chief Compliance Officer				Mar 16, 2022
Hua Wu	SVP Research & Product Dev.				Oct 22, 2021
Russell Beyer	Chief Financial Officer				Mar 14, 2023
Jay S. Skyler	Director				May 3, 2024
Bruce Kipp Erickson	Chief Operating Officer				Mar 16, 2022
Mark Conley	Interim Chief Financial Officer, Vice President of Finance				Jun 4, 2024
Frederick Finnegan	Chief Business Officer				Mar 16, 2022
Erick Lucera	Director				Apr 3, 2023
Jeffrey G. Spragens	Director				Feb 28, 2023
Thomas Charles Luke	Chief Medical Officer				Mar 16, 2022
Melissa Vera Ullerich	Chief Communications Officer				Mar 16, 2022
Scott Giberson	Director				Sep 13, 2022
William James Polvino	Director				Oct 22, 2021
Charles Hiram Randall	Chief Strategy Officer				Oct 22, 2021
Carlos N. Carillo	SVP Regulatory Affairs				Oct 22, 2021

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership